Drug
SHR3162
SHR3162 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 50.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(33%)
Phase Distribution
Ph phase_1
4
67%
Ph phase_2
2
33%
Phase Distribution
4
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
2(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(2)
Terminated(2)
Other(2)
Detailed Status
Terminated2
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 14 (66.7%)
Phase 22 (33.3%)
Trials by Status
terminated233%
unknown233%
completed233%
Recent Activity
0 active trials
Showing 5 of 6
terminatedphase_2
A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC
NCT04102124
terminatedphase_1
The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors
NCT03182673
unknownphase_2
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
NCT04355858
completedphase_1
A Trial of SHR3162 in Healthy Caucasian Volunteers
NCT04333134
unknownphase_1
Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects
NCT04341077
Clinical Trials (6)
Showing 6 of 6 trials
NCT04102124Phase 2
A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC
NCT03182673Phase 1
The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors
NCT04355858Phase 2
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
NCT04333134Phase 1
A Trial of SHR3162 in Healthy Caucasian Volunteers
NCT04341077Phase 1
Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects
NCT02759666Phase 1
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6